Semiconductor Field Effect Transistor Dosimeters Research Articles

Effective Dose Measurements of the Latest-Generation Angiographic System in Patients with Acute Stroke: A Comparison with the Newest Multidetector CT Generation.

Patients with acute ischemic stroke are increasingly triaged with one-stop management approaches, resulting in baseline imaging with a flat detector CT scanner. This study aimed to estimate the effective dose to a patient of a novel cervical and intracranial flat detector CT angiography and a flat detector CT perfusion protocol and to compare it with the effective dose of analogous multidetector row CT protocols. We estimated the effective dose to the patient according to the International Commission on Radiological Protection 103 using an anthropomorphic phantom with metal oxide semiconductor field effect transistor dosimeters. Placement was according to the organ map provided by the phantom manufacturer. We used 100 measurement points within the phantom, and 18 metal oxide semiconductor field effect transistor dosimeters were placed on the surface of the phantom. All protocols followed the manufacturer's specifications, and patient positioning and collimation were performed as in routine clinical practice. Measurements were obtained on the latest-generation angiography and multidetector row CT systems with identical placement of the metal oxide semiconductor field effect transistor dosimeters. The estimated effective doses of the investigated perfusion protocols were 4.52 mSv (flat detector CT perfusion without collimation), 2.88 mSv (flat detector CT perfusion with collimation), and 2.17 mSv (multidetector row CT perfusion). A novel protocol called portrait flat detector CT angiography that has a z-axis coverage area comparable with that of multidetector row CT angiography had an estimated effective dose of 0.91 mSv, while the dose from multidetector row CT was 1.35 mSv. The estimated effective dose to the patient for flat detector CT perfusion and angiography on a modern biplane angiography system does not deviate substantially from that of analogous multidetector row CT protocols.

Impact of thyroid gland shielding on radiation doses in dental cone beam computed tomography with small and medium fields of view

The purpose of this study was to evaluate the impact of thyroid gland shielding on radiation doses in dental cone beam computed tomography (CBCT) with small and medium fields of view (FOVs). Six CBCT protocols were investigated by exposing an adult anthropomorphic male phantom head without and with thyroid shielding, using 4 small (4×5 cm) and 2 medium (10×6 cm) FOVs. Twenty metal oxide semiconductor field-effect transistor dosimeters were placed in the phantom head to measure absorbed doses and calculate equivalent doses at 11 sites. Effective doses were calculated based on the tissue weighting factors in International Commission on Radiological Protection Publication 103. The data were analyzed using the independent samples t test. Thyroid gland shielding led to significant equivalent dose reductions in many tissues for all protocols. Equivalent dose reductions to the thyroid were significant in all 6 protocols (P ≤ .037). Significant reduction depended on the FOV and ranged between 24.5% and 42.6% for the thyroid gland and 4.9% and 34.5% for other tissues and organs. Effective doses were significantly lower in all protocols (P ≤ .016). Thyroid gland shielding protects the thyroid gland and other organs and should be utilized with all CBCT examinations where feasible.

Application of Patient-Customized Cast Type M3 Wax Bolus using a 3D printing for Photon Beam Radiation Therapy in Patients with Scalp Malignant Tumor

Introduction: We investigated the usefulness of patient-customized cast type M3 wax bolus (MWB) in radiation therapy in scalp malignant tumor patients by 3D conformal radiation therapy (3D CRT) and intensity-modulated radiation therapy (IMRT). Material and Methods: A helmet-type polylactic acid (PLA) hollow model was fabricated using a 3D Printing, and the molten MWB was poured into the mold and allowed to harden. Subsequently, a solid MWB head cast was obtained by removing the PLA. The radiation volume was verified using a metal oxide semiconductor field-effect transistor (MOSFET) dosimeter and EBT3 film. Results: Radiation dose verification was performed at the anterior, right, and left angles of planning tumor volume. The error rate demonstrated a maximum value of 5.5% and an average of 3.3% using the MOSFET dosimeter, and a maximum value of 7.0% and an average of 5.4% applying the EBT3 film. The homogeneity indices of the treatment plans were obtained as 0.09 and 0.12 using 3D CRT and IMRT, respectively. Moreover, the conformity number of the treatment plans was reported as 0.79 using 3D CRT and 0.81 applying IMRT. Conclusion: The density of the MWB head cast was 1.05 g/cm3 which is closer to that of the equivalent tissue than the existing helmet type bolus material. In addition, it reduces the processing time and associated pain during custom manufacturing and has little air gaps. Therefore, it can be considered an effective method for the treatment of patients with scalp malignant tumors.

Application of 3D-print silica bolus for nasal NK/T-cell lymphoma radiation therapy.

The aim of the study was to evaluate the clinical feasibility of a 3D-print silica bolus for nasal NK/T-cell lymphoma radiation therapy. Intensity modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) plans were designed using an anthropomorphic head phantom with a 3D-print silica bolus and other kinds of bolus used clinically, and the surface dose was measured by a metal oxide semiconductor field-effect transistor (MOSFET) dosimeter. Four nasal NK/T patients with or without 3D-print silica bolus were treated and the nose surface dose was measured using a MOSFET dosimeter during the first treatment. Plans for the anthropomorphic head phantom with 3D-print bolus have more uniform dose and higher conformity of the planning target volume (PTV) compared to other boluses; the homogeneity index (HI) and conformity index (CI) of the VMAT plan were 0.0589 and 0.7022, respectively, and the HI and CI of the IMRT plan were 0.0550 and 0.7324, respectively. The MOSFET measurement results showed that the surface dose of the phantom with 3D-print bolus was >180 cGy, and that of patients with 3D-print bolus was higher than patients without bolus. The air gap volume between the 3D-print bolus and the surface of patients was <0.3 cc. The 3D-print silica bolus fitted well on the patient’s skin, effectively reducing air gaps between bolus and patient surface. Meanwhile, the 3D-print silica bolus provided patients with higher individuation, and improved the conformity and uniformity of the PTV compared to other kinds of boluses.

End-to-end test and MOSFET in vivo skin dosimetry for 192Ir high-dose-rate brachytherapy of chronic psoriasis.

PurposeThis study was performed using end-to-end testing and real-time in vivo skin dose measurements, using metal oxide semiconductor field effect transistor (MOSFET) dosimeters on our first chronic psoriasis patient treated with iridium-192 (192Ir) high-dose-rate (HDR) brachytherapy (BT).Material and methodsTreatment delivery was planned with the prescription dose of 1.8 Gy to a 3 mm depth for 12 fractions, using our custom-fabricated surface mold and Varian soft catheters. The optimal technique to provide an adequate and acceptable skin dose as well as its feasibility were evaluated by an end-to-end exercise using a perspex finger phantom. The accuracy and reliability of MOSFET dose measurement was explored with a thermoluminescence dosimetry (TLD) before being used in vivo to monitor skin doses during treatment delivery for each BT fraction.ResultsUsing custom-made surface mold (2.4 mm Med-Tec thermoplastic mask for hand fixation and 5 applicators attached to each finger for dose delivery), the optimal skin dose on the phantom was obtained without the need for additional bolus to increase thickness of applicator. We acquired mean skin doses at different skin depths from various dose-volume parameters of no-bolus and 3 mm-added bolus plans. They were 125% and 110% (1 mm), 120% and 108% (2 mm), and 114% and 106% (3 mm), respectively. There was excellent agreement between MOSFET and TLD for 192Ir HDR-BT within ±3% (mean 2.65%, SD = 2.05%). With no energy correction, MOSFET overestimated the Acuros BV surface doses by up to 7% in the phantom study and in the clinical case.ConclusionsWe demonstrated achievable HDR-BT for our first case of nail bed psoriasis. The end-to-end exercise was an efficient methodology to evaluate new feasibility for this technique. Real-time dose monitoring using MOSFET was an effective and reliable tool to ensure treatment quality and patient safety.

THE IMPACT OF OBESITY ON ABDOMINAL CT RADIATION DOSE AND IMAGE QUALITY.

The aim of this study was to evaluate how iterative reconstruction can compensate for the noise increase in low radiation dose abdominal computed tomography (CT) technique for large size patients and the general impact of obesity on abdominal organ doses and image quality in CT. An anthropomorphic phantom layered with either none or a single layer of 3-cm- thick circumferential animal fat packs to simulate obese patients was imaged using a 128MDCT scanner. Abdominal protocols (n = 12) were applied using automatic tube current modulation (ATCM) with various quality reference mAs (150, 200, 250 and 300). kVs of 100, 120 and 140 were used for each mAs selection. Metal oxide semiconductor field effect transistor dosimeters (MOSFET) measured internal organ dose. All images produced were reconstructed with filtered back projection (FBP) and sinogram affirmed iterative reconstruction (SAFIRE) (3, 4 and 5) and objective noise was measured within three regions of interest at the level of L4-L5. Organ doses varied from 0.12 to 41.9 mGy, the spleen received the highest doses for both phantom sizes. Compared to the phantom simulating average size, the obese phantom was associated with up to twofold increase in delivered mAs, dose length product (DLP) and computed tomography dose index (CTDIvol) for the matched mAs selection (p < 0.05). However, organ dose increased by 50% only. The use of 100 kV resulted in a 40% lower dose (p < 0.05) compared to 120 kV and the associated noise increase was improved by SAFIRE (5) use, which resulted in 60% noise reduction compared to FBP (p < 0.05). When combined with iterative reconstruction, low kV is feasible for obese patients to optimise radiation dose and maintain objective image quality.

OA249] Experimental validation of a Monte Carlo code for internal breast dosimetry in mammography

Purpose To validate Monte Carlo (MC) simulations in absolute terms at the local dose deposition level for breast dosimetry applications using new experimental methodologies. Methods Three types of dose measurement devices were used for this study; thermoluminescent dosimeters (TLD-100H), metal oxide semiconductor field-effect transistor dosimeters (MOSFET, model TN-1002RD), and GafChromicTM films (model XR-QA2). First, experimental methodologies were developed and the performance of each of the three dosimeter technologies tested using a monoenergetic synchrotron-based setup. For validation under clinical conditions, a clinical digital mammography system (Mammomat INSPIRATION, Siemens Healthcare, Forchheim, Germany) and two phantoms, a semi-cylindrical homogeneous 50% glandular density phantom, and a heterogeneous anthropomorphic breast phantom, were used. MC simulations reproducing the experimental conditions were performed using code based on the Geant4 toolkit. Experimental and simulated 2D-dose maps and dose profiles for different depths in the axial-phantom plane were compared. Results The dosimeters have an energy-dependent response (it increases by ∼ 48% for XR-QA2 films and by ∼ 37% for MOSFET in the energy interval 18–28 keV), resulting in the need for calibration at each phantom depth to be investigated to obtain accurate measurements. The developed experimental methodologies allow for dose measurements with uncertainty levels of ∼ 5% (one combined standard uncertainty) at the entrance surface, up to ∼ 9% 4 cm deep inside the phantom. This increase in uncertainty is due to the decrease in dose with increasing phantom depth, which is reduced by 93% after 4 cm of the homogeneous phantom. In a heterogeneous background, dosimeters are able to detect local dose gradients of up to 46% between the boundaries of two materials. The MC-based estimates of the dose matched, to within one combined standard uncertainty, with the experimental ones for all three dosimeters technologies and for all tested depths. Conclusions The developed experimental methodologies allow for internal breast dose estimation with good accuracy. These procedures could be successfully applied to validate MC code at the local dose level and in absolute terms. The validation in a heterogeneous, anthropomorphic breast phantom is crucial to the development of a new breast model and dosimetry method.

Internal breast dosimetry in mammography: Monte Carlo validation in homogeneous and anthropomorphic breast phantoms with a clinical mammography system.

PurposeTo validate Monte Carlo (MC)‐based breast dosimetry estimations using both a homogeneous and a 3D anthropomorphic breast phantom under polyenergetic irradiation for internal breast dosimetry purposes.MethodsExperimental measurements were performed with a clinical digital mammography system (Mammomat Inspiration, Siemens Healthcare), using the x‐ray spectrum selected by the automatic exposure control and a tube current‐exposure time product of 360 mAs. A homogeneous 50% glandular breast phantom and a 3D anthropomorphic breast phantom were used to investigate the dose at different depths (range 0–4 cm with 1 cm steps) for the homogeneous case and at a depth of 2.25 cm for the anthropomorphic case. Local dose deposition was measured using thermoluminescent dosimeters (TLD), metal oxide semiconductor field‐effect transistor dosimeters (MOSFET), and GafChromic™ films. A Geant4‐based MC simulation was modified to match the clinical experimental setup. Thirty sensitive volumes (3.2 × 3.2 × 0.38 mm3) on the axial‐phantom plane were included at each depth in the simulation to characterize the internal dose variation and compare it to the experimental TLD and MOSFET measurements. The experimental 2D dose maps obtained with the GafChromic™ films were compared to the simulated 2D dose distributions.ResultsDue to the energy dependence of the dosimeters and due to x‐ray beam hardening, dosimeters based on these three technologies have to be calibrated at each depth of the phantom. As expected, the dose was found to decrease with increasing phantom depth, with the reduction being ~93% after 4 cm for the homogeneous breast phantom. The 2D dose map showed nonuniformities in the dose distribution in the axial plane of the phantom. The mean combined standard uncertainty increased with phantom depth by up to 5.3% for TLD, 6.3% for MOSFET, and 9.6% for GafChromic™ film. In the case of a heterogeneous phantom, the dosimeters are able to detect local dose gradient variations. In particular, GafChromic™ film showed local dose variations of about 46% at the boundaries of two materials.ConclusionsResults showed a good agreement between experimental measurements (with TLD and MOSFET) and MC data for both homogeneous and anthropomorphic breast phantoms. Larger discrepancies are found when comparing the GafChromic™ dose values to the MC results due to the inherent less precise nature of the former.MC validations in a heterogeneous background at the level of local dose deposition and in absolute terms play a fundamental role in the development of an accurate method to estimate radiation dose. The potential introduction of a breast dosimetry model involving a nonhomogeneous glandular/adipose tissue composition makes the validation of internal dose distributions estimates crucial.

Patient Dose Comparison for Intraoperative Imaging Devices Used in Orthopaedic Lumbar Spinal Surgery.

Background:The aim of this study was to determine the amount of radiation exposure from intraoperative imaging during two-level and four-level lumbar fusions.Methods:Five imaging systems were studied: multidetector CT (MDCT) scanner (CT A); two mobile CT units (CT B and CT C); a C-arm (D); and fluoroscopy (E). Metal oxide semiconductor field effect transistor dosimeters measured doses at 25 organ locations using an anthropomorphic phantom. A fat-equivalent phantom was used to simulate an obese body mass index (BMI).Results:The effective dose (ED) for C-arm D was estimated using commercial software. The ED for others was computed from the measured mean organ doses. EDs for a normal BMI patient, receiving a four-level fusion, are as follows: CT A (12.00 ± 0.30 mSv), CT B (5.90 ± 0.25 mSv), CT C (2.35 ± 0.44 mSv), C-arm D (0.44 mSv), and fluoroscopy E (0.30 ± 0.3 mSv). The rankings are consistent across all three BMI values except CT C and fluoroscopy E, which peaked in the overweight size because of system limitations. The other machines' ED trended with patient BMI.Conclusion:The dose reduction protocols were confirmed according to the manufacturer's specifications. The results of this study emphasize the need for the appropriate selection of the imaging system, especially because the type of device could have a substantial effect on patient radiation risk.

Radiation dose in non-dental cone beam CT applications: a systematic review.

Radiation-induced health risks are broadly questioned in the literature. As cone beam computed tomography (CBCT) is increasingly used in non-dental examinations, its effective dose needs to be known. This study aimed to review the published evidence on effective dose of non-dental CBCT for diagnostic use by focusing on dosimetry system used to estimate dose. A systematic review of the literature was performed on 12 November 2017. All the literature up to this date was included. The PubMed and web of science databases were searched. Studies were screened for inclusion based on defined inclusion and exclusion criteria according to the preferred reporting items for systematic reviews. Fifteen studies met the inclusion criteria and were included in our review. Thirteen and two of them examined one and two anatomical areas, respectively. The anatomical areas were: ear (6), paranasal sinuses (4), ankle (3), wrist (2), knee (1), and cervical spine (1). Effective dose was estimated by different methods: (i) RANDO phantom associated with thermoluminescent dosimeters (6), metal oxide semiconductor field-effect transistor dosimeters (3), and optically stimulated luminescent dosimeters (1). (ii) Scanner outputs, namely computed tomography dose index (1) and dose area product (2). (iii) Monte Carlo simulations (2). CBCT of extremities, cervical spine, ears and paranasal sinuses was found to be a low-dose volumetric imaging technique. Effective doses varied significantly because of different exposure settings of CBCT-units and different dosimetry systems used to estimate dose.

Internal breast dosimetry in mammography: Experimental methods and Monte Carlo validation with a monoenergetic x-ray beam.

To investigate the performance, such as energy dependence and sensitivity, of thermoluminescent dosimeters (TLD), metal oxide semiconductor field-effect transistor dosimeters (MOSFET), and GafChromic™ films, and to validate the estimates of local dose deposition of a Monte Carlo (MC) simulation for breast dosimetry applications. Experimental measurements were performed using a monoenergetic beam at the ELETTRA synchrotron radiation light source (Trieste, Italy). The three types of dosimeters were irradiated in a plane transversal to the beam axis and calibrated in terms of air kerma. The sensitivity of MOSFET dosimeters and GafChromic™ films was evaluated in the range of 18-28 keV. Three different calibration curves for the GafChromic™ films were tested (logarithmic, rational, and exponential functions) to evaluate the best-fit curve in the dose range of 1-20 mGy. Internal phantom dose measurements were performed at 20 keV for four different depths (range 0-3 cm, with 1 cm steps) using a homogeneous 50% glandular breast phantom. A GEANT4 MC simulation was modified to match the experimental setup. Thirty sensitive volumes, on the axial-phantom plane were included at each depth in the simulation to characterize the internal dose variation and compare it to the experimental TLD and MOSFET measurements. Experimental 2D dose maps were obtained with the GafChromic™ films and compared to the simulated 2D dose distributions estimated with the MC simulations. The sensitivity of the MOSFET dosimeters and GafChromic™ films increased with x-ray energy, by up to 37% and 48%, respectively. Dose-response curves for the GafChromic™ film result in an uncertainty lower than 5% above 6 mGy, when a logarithmic relationship is used in the dose range of 1-10 mGy. All experimental values fall within the experimental uncertainty and a good agreement (within 5%) is found against the MC simulation. The dose decreased with increasing phantom depth, with the reduction being ~80% after 3 cm. The uncertainty of the empirical measurements makes the experimental values compatible with a flat behavior across the phantom slab for all the investigated depths, while the MC points to a dose profile with a maximum toward the center of the phantom. The calibration procedures and the experimental methodologies proposed lead to good accuracy for internal breast dose estimation. In addition, these procedures can be successfully applied to validate MC codes for breast dosimetry at the local dose level. The agreement among the experimental and MC results not only shows the correctness of the empirical procedures used but also of the simulation parameters.

Assessment of female breast dose for thoracic cone-beam CT using MOSFET dosimeters.

Objective: To assess the breast dose during a routine thoracic cone-beam CT (CBCT) check with the efforts to explore the possible dose reduction strategy.Materials and Methods: Metal oxide semiconductor field-effect transistor (MOSFET) dosimeters were used to measure breast surface doses during a thorax kV CBCT scan in an anthropomorphic phantom. Breast doses for different scanning protocols and breast sizes were compared. Dose reduction was attempted by using partial arc CBCT scan with bowtie filter. The impact of this dose reduction strategy on image registration accuracy was investigated.Results: The average breast surface doses were 20.02 mGy and 11.65 mGy for thoracic CBCT without filtration and with filtration, respectively. This indicates a dose reduction of 41.8% by use of bowtie filter. It was found 220° partial arc scanning significantly reduced the dose to contralateral breast (44.4% lower than ipsilateral breast), while the image registration accuracy was not compromised.Conclusions: Breast dose reduction can be achieved by using ipsilateral 220° partial arc scan with bowtie filter. This strategy also provides sufficient image quality for thorax image registration in daily patient positioning verification.

Estimating Effective Dose of Radiation From Pediatric Cardiac CT Angiography Using a 64-MDCT Scanner: New Conversion Factors Relating Dose-Length Product to Effective Dose.

The purpose of this study is to determine the conversion factors that enable accurate estimation of the effective dose (ED) used for cardiac 64-MDCT angiography performed for children. Anthropomorphic phantoms representative of 1- and 10-year-old children, with 50 metal oxide semiconductor field-effect transistor dosimeters placed in organs, underwent scanning performed using a 64-MDCT scanner with different routine clinical cardiac scan modes and x-ray tube potentials. Organ doses were used to calculate the ED on the basis of weighting factors published in 1991 in International Commission on Radiological Protection (ICRP) publication 60 and in 2007 in ICRP publication 103. The EDs and the scanner-reported dose-length products were used to determine conversion factors for each scan mode. The effect of infant heart rate on the ED and the conversion factors was also assessed. The mean conversion factors calculated using the current definition of ED that appeared in ICRP publication 103 were as follows: 0.099 mSv · mGy-1 · cm-1, for the 1-year-old phantom, and 0.049 mSv · mGy-1 · cm-1, for the 10-year-old phantom. These conversion factors were a mean of 37% higher than the corresponding conversion factors calculated using the older definition of ED that appeared in ICRP publication 60. Varying the heart rate did not influence the ED or the conversion factors. Conversion factors determined using the definition of ED in ICRP publication 103 and cardiac, rather than chest, scan coverage suggest that the radiation doses that children receive from cardiac CT performed using a contemporary 64-MDCT scanner are higher than the radiation doses previously reported when older chest conversion factors were used. Additional up-to-date pediatric cardiac CT conversion factors are required for use with other contemporary CT scanners and patients of different age ranges.

MO-FG-CAMPUS-IeP2-03: Validation of an SSDE-To-Organ-Dose Calculation Methodology Developed for Pediatric CT in An Adult Population

Purpose: To discover if a previously published methodology for estimating patient-specific organ dose in a pediatric population (5–55kg) is translatable to the adult sized patient population (> 55 kg). Methods: An adult male anthropomorphic phantom was scanned with metal oxide semiconductor field effect transistor (MOSFET) dosimeters placed at 23 organ locations in the chest and abdominopelvic regions to determine absolute organ dose. Organ-dose-to-SSDE correlation factors were developed by dividing individual phantom organ doses by SSDE of the phantom; where SSDE was calculated at the center of the scan volume of the chest and abdomen/pelvis separately. Organ dose correlation factors developed in phantom were multiplied by 28 chest and 22 abdominopelvic patient SSDE values to estimate organ dose. The median patient weight from the CT examinations was 68.9 kg (range 57–87 kg) and median age was 17 years (range 13–28 years). Calculated organ dose estimates were compared to published Monte Carlo simulated patient and phantom results. Results: Organ-dose-to-SSDE correlation was determined for a total of 23 organs in the chest and abdominopelvic regions. For organs fully covered by the scan volume, correlation in the chest (median 1.3; range 1.1–1.5) and abdominopelvic (median 0.9; range 0.7–1.0) was 1.0 ± 10%. For organs that extended beyond the scan volume (i.e. skin bone marrow and bone surface) correlation was determined to be a median of 0.3 (range 0.1–0.4). Calculated patient organ dose using patient SSDE agreed to better than 6% (chest) and 15% (abdominopelvic) to published values. Conclusion: This study demonstrated that our previous published methodology for calculating organ dose using patient-specific SSDE for the chest and abdominopelvic regions is translatable to adult sized patients for organs fully covered by the scan volume.

Characterization of MOSFET Dosimeter Angular Response Using a Spherical Phantom for Fluoroscopic Dosimetry.

Metal-Oxide Semiconductor Field-Effect Transistor (MOSFET) dosimeters, placed in anthropomorphic phantoms, are a standard method for organ dosimetry in medical x-ray imaging applications. However, many x-ray applications, particularly fluoroscopy procedures, use variable projection angles. During dosimetry, the MOSFET detector active area may not always be perpendicular to the x-ray beam. The goal of this study was to characterize the dosimeter's angular response in the fluoroscopic irradiation involved in pediatric cardiac catheterization procedures, during which a considerable amount of fluoroscopic x-ray irradiation is often applied from various projection angles. A biological x-ray irradiator was used to simulate the beam quality of a biplane fluoroscopy imaging system. A custom-designed acrylic spherical scatter phantom was fabricated to measure dosimeter response (in mV) in two rotational axes, axial (ψ) and normal-to-axial (θ), in 30° increments, as well as four common oblique angles used in cardiac catheterization: a) 90° Left Anterior Oblique (LAO); b) 70° LAO/ 20° Cranial; c) 20° LAO/ 15° Cranial; and d) 30° Right Anterior Oblique (RAO). All results were normalized to the angle where the dosimeter epoxy is perpendicular to the beam or the Posterior-Anterior projection angle in the clinical setup. The relative response in the axial rotation was isotropic (within ± 10% deviation); that in the normal-to-axial rotation was isotropic in all angles except the ψ = 270° angle, where the relative response was 83 ± 9%. No significant deviation in detector response was observed in the four common oblique angles, with their relative responses being: a) 102 ± 3%; b) 90 ± 3%; c) 92 ± 3%; and d) 95 ± 3%, respectively. These angular correction factors will be used in future dosimetry studies for fluoroscopy. The spherical phantom may be useful for other applications, as it allows the measurement of dosimeter response in virtually all angles in the 3-dimensional spherical coordinates.

Radiation Dosimetry for Ureteroscopy Patients: A Phantom Study Comparing the Standard and Obese Patient Models.

To determine the effect of obesity on radiation exposure during simulated ureteroscopy. A validated anthropomorphic adult male phantom with a body mass index (BMI) of approximately 24 kg/m(2), was positioned to simulate ureteroscopy. Padding with radiographic characteristics of human fat was placed around the phantom to create an obese model with BMI of 30 kg/m(2). Metal oxide semiconductor field effect transistor (MOSFET) dosimeters were placed at 20 organ locations in both models to measure organ dosages. A portable C-arm was used to provide fluoroscopic x-ray radiation to simulate ureteroscopy. Organ dose rates were calculated by dividing organ dose by fluoroscopy time. Effective dose rate (EDR, mSv/sec) was calculated as the sum of organ dose rates multiplied by corresponding ICRP 103 tissue weighting factors. The mean EDR was significantly increased during left ureteroscopy in the obese model at 0.0092 ± 0.0004 mSv/sec compared with 0.0041 ± 0.0003 mSv/sec in the nonobese model (P < 0.01), as well as during right ureteroscopy at 0.0061 ± 0.0002 and 0.0036 ± 0.0007 mSv/sec in the obese and nonobese model, respectively (P < 0.01). EDR during left ureteroscopy was significantly greater than right ureteroscopy in the obese model (P = 0.02). Fluoroscopy during ureteroscopy contributes to the overall radiation dose for patients being treated for nephrolithiasis. Obese patients are at even higher risk because of increased exposure rates during fluoroscopy. Every effort should be made to minimize the amount of fluoroscopy used during ureteroscopy, especially with obese patients.

TU‐E‐201‐00: Eye Lens Dosimetry for Patients and Staff

TU‐E‐201‐00: Eye Lens Dosimetry for Patients and Staff

TU‐E‐201‐01: Methods for Eye Lens Dosimetry and Studies On Lens Opacities with Interventionists

TU‐E‐201‐01: Methods for Eye Lens Dosimetry and Studies On Lens Opacities with Interventionists

TU‐E‐201‐03: Eye Lens Dosimetry in Radiotherapy Using Contact Lens‐Shaped Applicator

TU‐E‐201‐03: Eye Lens Dosimetry in Radiotherapy Using Contact Lens‐Shaped Applicator

TU‐E‐201‐02: Eye Lens Dosimetry From CT Perfusion Studies

TU‐E‐201‐02: Eye Lens Dosimetry From CT Perfusion Studies